139 related articles for article (PubMed ID: 1963641)
1. Clues to the multi-phasic inhibitory action of botulinum neurotoxins on release of transmitters.
Dolly JO; Ashton AC; McInnes C; Wadsworth JD; Poulain B; Tauc L; Shone CC; Melling J
J Physiol (Paris); 1990; 84(3):237-46. PubMed ID: 1963641
[TBL] [Abstract][Full Text] [Related]
2. Microtubule-dissociating drugs and A23187 reveal differences in the inhibition of synaptosomal transmitter release by botulinum neurotoxins types A and B.
Ashton AC; Dolly JO
J Neurochem; 1991 Mar; 56(3):827-35. PubMed ID: 1847184
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of neurotransmitter release by botulinum neurotoxins and tetanus toxin at Aplysia synapses: role of the constituent chains.
Poulain B; Mochida S; Wadsworth JD; Weller U; Habermann E; Dolly JO; Tauc L
J Physiol (Paris); 1990; 84(4):247-61. PubMed ID: 1981913
[TBL] [Abstract][Full Text] [Related]
4. [Mechanisms of action of botulinum toxins and neurotoxins].
Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release.
Maisey EA; Wadsworth JD; Poulain B; Shone CC; Melling J; Gibbs P; Tauc L; Dolly JO
Eur J Biochem; 1988 Nov; 177(3):683-91. PubMed ID: 3197726
[TBL] [Abstract][Full Text] [Related]
6. Multiple domains of botulinum neurotoxin contribute to its inhibition of transmitter release in Aplysia neurons.
Poulain B; Wadsworth JD; Shone CC; Mochida S; Lande S; Melling J; Dolly JO; Tauc L
J Biol Chem; 1989 Dec; 264(36):21928-33. PubMed ID: 2574722
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.
Foran P; Lawrence GW; Shone CC; Foster KA; Dolly JO
Biochemistry; 1996 Feb; 35(8):2630-6. PubMed ID: 8611567
[TBL] [Abstract][Full Text] [Related]
8. Effects of Ca2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction.
Katz E; Protti DA; Ferro PA; Rosato Siri MD; Uchitel OD
Br J Pharmacol; 1997 Aug; 121(8):1531-40. PubMed ID: 9283685
[TBL] [Abstract][Full Text] [Related]
9. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
Simpson LL; Dasgupta BR
J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A targets RhoB to inhibit lysophosphatidic acid-stimulated actin reorganization and acetylcholine release in nerve growth factor-treated PC12 cells.
Ishida H; Zhang X; Erickson K; Ray P
J Pharmacol Exp Ther; 2004 Sep; 310(3):881-9. PubMed ID: 15140914
[TBL] [Abstract][Full Text] [Related]
11. Is the light chain subcellular localization an important factor in botulinum toxin duration of action?
Fernández-Salas E; Ho H; Garay P; Steward LE; Aoki KR
Mov Disord; 2004 Mar; 19 Suppl 8():S23-34. PubMed ID: 15027051
[TBL] [Abstract][Full Text] [Related]
12. Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions.
Molgo J; Comella JX; Angaut-Petit D; Pecot-Dechavassine M; Tabti N; Faille L; Mallart A; Thesleff S
J Physiol (Paris); 1990; 84(2):152-66. PubMed ID: 2290130
[TBL] [Abstract][Full Text] [Related]
13. Botulinum neurotoxin and dendrotoxin as probes for studies on transmitter release.
Dolly JO; Halliwell JV; Black JD; Williams RS; Pelchen-Matthews A; Breeze AL; Mehraban F; Othman IB; Black AR
J Physiol (Paris); 1984; 79(4):280-303. PubMed ID: 6152294
[TBL] [Abstract][Full Text] [Related]
14. ADP-ribosylation of cerebrocortical synaptosomal proteins by cholera, pertussis and botulinum toxins.
Ashton AC; Edwards K; Dolly JO
Toxicon; 1990; 28(8):963-73. PubMed ID: 1981953
[TBL] [Abstract][Full Text] [Related]
15. Ca2(+)-dependent noradrenaline release from permeabilised PC12 cells is blocked by botulinum neurotoxin A or its light chain.
McInnes C; Dolly JO
FEBS Lett; 1990 Feb; 261(2):323-6. PubMed ID: 2311761
[TBL] [Abstract][Full Text] [Related]
16. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
[TBL] [Abstract][Full Text] [Related]
17. External pH changes affect NMDA-evoked and spontaneous release of cholecystokinin, somatostatin and noradrenaline from rat cerebrocortical nerve endings.
Gemignani A; Paudice P; Longordo F; Raiteri M
Neurochem Int; 2004 Oct; 45(5):677-85. PubMed ID: 15234110
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of transmitter release by botulinum neurotoxin A. Contribution of various fragments to the intoxication process.
Poulain B; Wadsworth JD; Maisey EA; Shone CC; Melling J; Tauc L; Dolly JO
Eur J Biochem; 1989 Oct; 185(1):197-203. PubMed ID: 2572418
[TBL] [Abstract][Full Text] [Related]
19. Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.
Dolly JO; Wang J; Zurawski TH; Meng J
FEBS J; 2011 Dec; 278(23):4454-66. PubMed ID: 21645262
[TBL] [Abstract][Full Text] [Related]
20. Action of botulinum A toxin and tetanus toxin on synaptic transmission.
Dreyer F; Becker C; Bigalke H; Funk J; Penner R; Rosenberg F; Ziegler M
J Physiol (Paris); 1984; 79(4):252-8. PubMed ID: 6152293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
